Trials / Sponsors / Endogena Therapeutics, Inc
Endogena Therapeutics, Inc
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis P Retinitis Pigmentosa, Retinitis Pigmentosa Syndrome | Phase 1 / Phase 2 | 2022-06-02 |